Citadel Advisors
ORGO icon

Citadel Advisors’s Organogenesis Holdings ORGO Stock Holding History

Citadel Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-900
Closed -$3.89K – 14359
2025
Q1 		$3.89K Sell
900
-3,000
-77% -$12.1K ﹤0.01% 13930
2024
Q4 		$12.5K Buy
3,900
+3,400
+680% +$11.4K ﹤0.01% 13497
2024
Q3 		$1.43K Buy
500
+100
+25% +$280 ﹤0.01% 13851
2024
Q2 		$1.12K Sell
400
-600
-60% -$1.61K ﹤0.01% 13860
2024
Q1 		$2.84K Sell
1,000
-2,700
-73% -$9.18K ﹤0.01% 13967
2023
Q4 		$15.1K Sell
3,700
-8,500
-70% -$23.8K ﹤0.01% 12848
2023
Q3 		$38.8K Sell
12,200
-900
-7% -$2.86K ﹤0.01% 12034
2023
Q2 		$43.5K Sell
13,100
-18,000
-58% -$53.2K ﹤0.01% 11972
2023
Q1 		$66.2K Buy
31,100
+22,200
+249% +$54.8K ﹤0.01% 11807
2022
Q4 		$23.9K Buy
+8,900
New +$26K ﹤0.01% 12996
2022
Q3 		– Sell
-17,100
Closed -$83K – 13321
2022
Q2 		$83K Sell
17,100
-1,700
-9% -$10.5K ﹤0.01% 11571
2022
Q1 		$143K Buy
18,800
+500
+3% +$3.87K ﹤0.01% 11908
2021
Q4 		$169K Sell
18,300
-21,500
-54% -$228K ﹤0.01% 12110
2021
Q3 		$567K Sell
39,800
-9,000
-18% -$140K ﹤0.01% 9568
2021
Q2 		$811K Buy
+48,800
New +$910K ﹤0.01% 8909

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Citadel Advisors's ORGO Position: Q1 2026 in Review

Citadel Advisors reduced its Organogenesis Holdings (ORGO) stake by 4.4% in Q1 2026, selling an estimated $86.4K and leaving 544,235 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #7090.

Citadel Advisors first reported a position in ORGO in Q2 2019 and has held it in 25 quarters since. The position peaked at $9.81M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Citadel Advisors held 544,235 shares of Organogenesis Holdings worth $1.29M as of Q1 2026.
  • Citadel Advisors sold 24,931 Organogenesis Holdings shares in Q1 2026, an estimated $86.4K.
  • Organogenesis Holdings made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7090 holding.
  • Citadel Advisors first reported a position in Organogenesis Holdings in Q2 2019 and has held it in 25 quarters since.
  • Citadel Advisors's Organogenesis Holdings position peaked at $9.81M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.